This is a rare condition where the body doesn't have enough of certain enzymes needed for normal function. These enzymes help break down certain molecules. It happens because of problems with the vitamin biotin.
Every report comes from a Lived member, sent anonymously.
Have you tried Biotin for Multiple Carboxylase Deficiency?
Multiple carboxylase deficiency is an inherited metabolic disorder in which the body cannot make proper use of biotin, a B vitamin. Several enzymes called carboxylases need biotin to break down proteins, fats and carbohydrates. When these enzymes cannot work, food is not processed normally and acids and other harmful byproducts build up in the body. The name covers two related genetic conditions. In biotinidase deficiency, the body cannot recycle biotin. Symptoms usually begin after the first few weeks or months of life, and a milder partial form may cause problems only during illness. In holocarboxylase synthetase deficiency, the body cannot attach biotin to the enzymes that need it. It typically appears within the first few months of life and can make a newborn seriously ill. Without treatment, either form can cause seizures, weak muscle tone, breathing problems, skin rash, hair loss and delayed development, and biotinidase deficiency can also lead to hearing and vision loss. What makes the condition so important to recognize is that it is treatable: daily biotin can prevent most of these problems, or improve them once they have started.
Multiple carboxylase deficiency is a genetic condition present from birth. It is caused by changes (variants) in one gene: the BTD gene in biotinidase deficiency and the HLCS gene in holocarboxylase synthetase deficiency. Both forms are inherited in an autosomal recessive pattern, meaning a child is affected only when they inherit a nonworking copy of the gene from each parent. Parents who each carry one copy are usually healthy and often learn they are carriers only when a child is diagnosed. When both parents are carriers, each pregnancy has a 1 in 4 (25%) chance of an affected child and a 1 in 2 chance of a child who is a carrier. Parents who are close blood relatives are more likely to carry the same gene change. In partial biotinidase deficiency, illness, infection or other physical stress can bring out symptoms. These are triggers for symptoms, not the cause of the condition.
In the United States, nearly all babies with biotinidase deficiency can be found through newborn screening, the heel-prick blood test done shortly after birth. A positive screen is not a diagnosis; it means confirmatory testing is needed quickly. A blood test of biotinidase enzyme activity confirms the condition and shows whether it is profound (less than 10% of normal activity) or partial (10% to 30% of normal). Testing the BTD gene helps when the enzyme result is unclear. Holocarboxylase synthetase deficiency is often suspected when a sick infant has a buildup of acid in the blood (metabolic acidosis) and a urine test shows a characteristic pattern of organic acids, the byproducts that accumulate when the carboxylases fail. Because these infants can look as if they have a severe infection, doctors check biotinidase activity and test the HLCS gene to tell the two forms apart. Newborn screening can sometimes pick up this form as well. Once the gene changes in a family are known, relatives can have carrier testing, and testing during a future pregnancy is possible.
The treatment is biotin, the same vitamin found in ordinary supplements, taken by mouth at doses far higher than food provides. Extra biotin supplies the carboxylase enzymes with enough of the vitamin to work, which stops the harmful buildup. Treatment begins as soon as the diagnosis is made and continues every day for life, because the underlying enzyme problem is permanent. The metabolic specialist decides the dose. Stopping biotin allows symptoms to return. In biotinidase deficiency, biotin works very well. Children who start it before symptoms appear develop normally. In children who already have symptoms, seizures often stop within minutes to hours of the first doses and other problems often improve, although hearing loss, vision problems and developmental delay that have already developed may not fully recover. Most people with holocarboxylase synthetase deficiency also respond well to biotin, but some respond only partly and need closer specialist management. A baby who is seriously ill at diagnosis is treated in the hospital while biotin takes effect. Genetic counseling helps families understand how the condition is inherited and what testing options exist for future pregnancies.
For a child diagnosed through newborn screening and treated from the start, biotinidase deficiency usually changes little about daily life beyond taking biotin every day, and development is expected to be normal. Because the dose is high, biotin can throw off some common blood tests, including thyroid tests and troponin (a test for heart damage), so tell any clinician or lab ordering blood work that the person takes biotin. People with the partial form are also treated, since untreated they can develop symptoms during illness. The outlook depends mostly on how early treatment began. When symptoms appeared before diagnosis, some effects can be permanent, particularly hearing loss, and children may need ongoing support for hearing, vision, development or learning. Holocarboxylase synthetase deficiency has a more variable course. Many children who start biotin early do well, but outcomes are less predictable, especially for the smaller group who respond only partly to treatment. In both forms, care continues over time with a metabolic (biochemical genetics) specialist, who follows growth, development and lab results.
Ask about testing for an infant or child with unexplained seizures, weak muscle tone, developmental delay, a persistent rash with hair loss, or hearing or vision loss, and for the brothers and sisters of anyone diagnosed. If you are called about an abnormal newborn screen, follow up right away, because confirming the diagnosis quickly lets treatment begin before symptoms. For someone already on treatment, contact the metabolic team promptly if rash, hair loss or other symptoms return. An infant with a seizure, unusual sleepiness or difficulty waking, trouble breathing, or poor feeding with repeated vomiting needs emergency care; tell the staff about the diagnosis or the abnormal screen.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Multiple Carboxylase Deficiency is like, what's helped you, or ask the community a question.